Naidoo Kalnisha, Pinder Sarah E
Cellular Pathology, Guy's and St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK; Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK.
Cancer Studies, King's College London, Guy's Hospital, 3rd Floor, Bermondsey Wing, Great Maze Pond, London, SE1 9RT, UK.
Surgeon. 2017 Apr;15(2):76-82. doi: 10.1016/j.surge.2016.07.002. Epub 2016 Aug 3.
Pathologists typically examine the sentinel lymph nodes excised from patients with invasive breast cancer more thoroughly than they have historically those from axillary lymph node clearance specimens. This, it is thought, increases the chances of detecting small metastatic foci (i.e. macrometastases (>2 mm), micrometastases (0.2-2 mm), or isolated tumour cell clusters (<0.2 mm or <200 cancer cells in one section)). However, the clinical significance of these small metastatic deposits remains unclear. Although an increasing nodal burden is known to proportionally decrease patient survival, the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial has, at the least, raised questions as to how best to manage nodal metastasis in early invasive breast cancer. These issues, and a brief overview of the biology of metastatic spread are presented in this review.
与过去对腋窝淋巴结清扫标本的检查相比,病理学家通常会更全面地检查从浸润性乳腺癌患者身上切除的前哨淋巴结。据认为,这增加了检测到小转移灶(即大转移灶(>2毫米)、微转移灶(0.2 - 2毫米)或孤立肿瘤细胞簇(<0.2毫米或每切片<200个癌细胞))的几率。然而,这些小转移灶的临床意义仍不明确。尽管已知淋巴结负担增加会相应降低患者生存率,但美国外科医师学会肿瘤学组(ACOSOG)Z0011试验至少对早期浸润性乳腺癌中淋巴结转移的最佳处理方式提出了疑问。本综述介绍了这些问题以及转移扩散生物学的简要概述。